These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 17525
1. The effects of delta9-tetrahydrocannabinol and cannabidiol on the metabolism of gonadal steroids in the rat. List A, Nazar B, Nyquist S, Harclerode J. Drug Metab Dispos; 1977; 5(3):268-72. PubMed ID: 17525 [Abstract] [Full Text] [Related]
2. Mechanism for inhibitory effect of cannabidiol on microsomal testosterone oxidation in male rat liver. Narimatsu S, Watanabe K, Yamamoto I, Yoshimura H. Drug Metab Dispos; 1988; 16(6):880-9. PubMed ID: 2907469 [Abstract] [Full Text] [Related]
5. Cytochrome P-450 isozymes in metabolic activation of delta 9-tetrahydrocannabinol by rat liver microsomes. Narimatsu S, Watanabe K, Matsunaga T, Yamamoto I, Imaoka S, Funae Y, Yoshimura H. Drug Metab Dispos; 1990; 18(6):943-8. PubMed ID: 1981541 [Abstract] [Full Text] [Related]
6. Pharmacological interaction of the effects of delta 9-trans-tetrahydrocannabinol and cannabidiol on serum corticosterone levels in rats. Zuardi AW, Teixeira NA, Karniol IC. Arch Int Pharmacodyn Ther; 1984 May; 269(1):12-9. PubMed ID: 6087750 [Abstract] [Full Text] [Related]
7. Effects of delta 9-tetrahydrocannabinol and cannabidiol on sodium-dependent high affinity choline uptake in the rat hippocampus. Lindamood C, Colasanti BK. J Pharmacol Exp Ther; 1980 May; 213(2):216-21. PubMed ID: 6245205 [Abstract] [Full Text] [Related]
8. Cytochrome P-450 isozymes involved in the oxidative metabolism of delta 9-tetrahydrocannabinol by liver microsomes of adult female rats. Narimatsu S, Watanabe K, Matsunaga T, Yamamoto I, Imaoka S, Funae Y, Yoshimura H. Drug Metab Dispos; 1992 May; 20(1):79-83. PubMed ID: 1347001 [Abstract] [Full Text] [Related]
9. Perinatal cannabinoid exposure: effects on hepatic cytochrome P-450 and plasma protein levels in male mice. Dalterio S, Thomford PJ, Michael SD, DeAngelo L, Mayfield D. Teratology; 1986 Apr; 33(2):195-201. PubMed ID: 3016935 [Abstract] [Full Text] [Related]
10. CYP2C-catalyzed delta9-tetrahydrocannabinol metabolism: kinetics, pharmacogenetics and interaction with phenytoin. Bland TM, Haining RL, Tracy TS, Callery PS. Biochem Pharmacol; 2005 Oct 01; 70(7):1096-103. PubMed ID: 16112652 [Abstract] [Full Text] [Related]
11. Development of tolerance to the prolongation of hexobarbitone sleeping time caused by cannabidiol. Borys HK, Ingall GB, Karler R. Br J Pharmacol; 1979 Sep 01; 67(1):93-101. PubMed ID: 497524 [Abstract] [Full Text] [Related]
12. Cannabidiol reverses the reduction in social interaction produced by low dose Delta(9)-tetrahydrocannabinol in rats. Malone DT, Jongejan D, Taylor DA. Pharmacol Biochem Behav; 2009 Aug 01; 93(2):91-6. PubMed ID: 19393686 [Abstract] [Full Text] [Related]
13. Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers. Roser P, Juckel G, Rentzsch J, Nadulski T, Gallinat J, Stadelmann AM. Eur Neuropsychopharmacol; 2008 Aug 01; 18(8):569-77. PubMed ID: 18544469 [Abstract] [Full Text] [Related]
14. Purification and characterization of a mouse liver cytochrome P-450 induced by cannabidiol. Bornheim LM, Correia MA. Mol Pharmacol; 1989 Sep 01; 36(3):377-83. PubMed ID: 2779523 [Abstract] [Full Text] [Related]